Back to search

Article

Pan-cancer molecular signatures connecting aspartate transaminase (AST) to cancer prognosis, metabolic and immune signatures

2024-03-04

Abstract excerpt

<h4>Background</h4> Serum aspartate transaminase (sAST) level is used routinely in conjunction with other clinical assays to assess liver health and disease. Increasing evidence suggests that sAST is associated with all-cause mortality and has prognostic value in several cancers, including gastrointestinal and urothelial cancers. Here, we undertake a systems approach to unravel molecular connections between AST a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1aaf6ce-f2dc-578b-8de1-926bb276e239
DOI
10.1101/2024.03.01.582939
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-cancer molecular signatures connecting aspartate transaminase (AST) to cancer prognosis, metabolic and immune signaturesDOI 10.1101/2024.03.01.582939
Select a neighboring publication to make it the new centre.